VIDAL
- Company typePrivate
- Founded1911
- HeadquartersIssy-les-moulineaux, France
- Headcount251–500
- GTM typeB2B
- OfferingSoftware
VIDAL firmographics
Firmographics- Name
- VIDAL
- Legal name
- VIDAL FRANCE
- Website
- https://vidalfrance.com
- Company type
- Private
- Founded year
- 1911
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Ownership category
- akta.pro rank
VIDAL industry classification
Industry- Product category
- Clinical Decision Support Software
- NAICS
- Software Publishers (5132)
- SIC
- Services-Misc Health & Allied Services, Nec (8090)
- akta.pro primary industry
- Medication Safety, Dosing & Drug Interaction CDS (HLACAGAB)
- akta.pro secondary industries
- Medication Safety, Pharmacovigilance & Adverse Event Reporting IT (HLACAKAK), Evidence-Based Guidelines, Knowledge Management & Content Authoring (HLACAGAD)
Keywords
Where VIDAL is headquartered
LocationHeadquarters
- HQ city
- Issy-les-moulineaux
- HQ country
- France
- HQ region
- Europe
Offices1 record
Markets served
VIDAL business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Revenue model
- Professional Software Subscriptions: Subscription-based access to VIDAL Expert and other professional solutions for healthcare practitioners, offering prescription assistance, drug information, and clinical decision support tools.
- B2B Licensing to Software Publishers: VIDAL licenses its medical database to over 280 software publishers who integrate the knowledge base into their healthcare software products (hospital systems, pharmacy management, medical office software).
- Enterprise Solutions for Healthcare Facilities: Hospital and healthcare establishment-specific solutions including VIDAL Hoptimal, VIDAL Sentinel, and integrated services for institutional healthcare settings.
- eVIDAL International Services: International licensing and services for healthcare organizations outside France, providing multilingual medical information solutions.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Freemium | Free | Free tier - VIDAL.fr and VIDAL Mobile |
| Subscription | Annual | Professional subscriptions - VIDAL Expert |
Go-to-market motion3 records
Distribution channels5 records
Marketing channels7 records
VIDAL product offering
Product offeringCore offering
VIDAL provides a validated medical knowledge base and clinical decision support system for healthcare professionals. Its products include desktop, web, and mobile solutions (VIDAL Expert, VIDAL.fr, VIDAL Mobile) that deliver drug monographs, drug interaction checking, contraindication alerts, therapeutic recommendations (VIDAL Recos), and prescription security modules. The company also licenses its knowledge base to over 280 healthcare software publishers and operates hospital and consumer health applications.
Product overview
VIDAL is a platform-plus-modules architecture centered on its core medication knowledge base containing over 200,000 health product references. The primary products include VIDAL Expert (desktop solution), VIDAL Mobile (mobile app), VIDAL.fr (web portal), and VIDAL Ma Santé (consumer app), complemented by hospital-specific solutions like VIDAL Hoptimal. Add-on modules include VIDAL Sécurisation and VIDAL Sentinel for prescription security, VIDAL Référentiel for data integration, and eVIDAL for partner access. The product portfolio extends through acquired subsidiaries: WEDA (online medical records), MonEcho (ultrasound management), and DrSanté (practice management software). VIDAL Recos provides validated therapeutic strategies, while VIDAL Campus and VIDAL Live offer e-learning and event platforms. The knowledge base integrates with over 280 third-party healthcare software applications across pharmacies, medical practices, hospitals, dental practices, and health centers.
Differentiator
Problem solved
Functional benefit
Brands
- VIDAL Expert: Complete medication decision support solution for physicians, providing comprehensive drug information, interaction checking, and prescription assistance
- VIDAL Mobile
- VIDAL.fr
- VIDAL Ma Santé
- VIDAL Expert Structure
- VIDAL Hoptimal
- VIDAL Sécurisation
- VIDAL Sentinel
- VIDAL Référentiel
- eVIDAL
- VIDAL Consult
- VIDAL Integrated
- VIDAL Recos
- VIDAL Campus
- VIDAL Live
- MonEcho
- DrSanté
- WEDA
Products and services
- VIDAL Expert The most comprehensive desktop medication decision support solution for physicians, providing access to the full VIDAL database including monographs, drug interactions, contraindications, and therapeutic recommendations.
- VIDAL Mobile Mobile application for iOS and Android providing on-the-go access to medication information, drug interactions, and prescription assistance for healthcare professionals.
- VIDAL.fr Online web portal providing medication information for liberal physicians, accessible via web browser with drug monographs, interactions, and prescription support.
- VIDAL Ma Santé Mobile application for the general public providing validated health information and medication guidance, referenced in France's national Mon espace Santé personal health record platform.
- VIDAL Hoptimal Intranet solution for hospital practitioners providing medication information, decision support, and access to the British National Formulary (BNF) within healthcare establishments.
- VIDAL Sécurisation CE Class 1 medical device module for prescription security, designed for integration into business software to identify medication risks, drug interactions, and non-conformities.
- VIDAL Sentinel Continuous prescription risk evaluation solution that monitors and assesses medication risks over time for healthcare facilities. Awarded CE Class IIb marking in May 2023, the first company in France to achieve this level.
- VIDAL Expert Structure Extended version of VIDAL Expert designed for healthcare structures and hospitals, offering enhanced organizational prescription management capabilities.
- eVIDAL Electronic access service providing VIDAL medical data in structured formats for software publisher integration and international licensing of the VIDAL knowledge base.
- WEDA Online medical record software for liberal healthcare professionals with patient management, prescription, teletransmission, and DMP/Mon espace Santé integration. Holds Ségur, ASIP V2, LAP HAS v2, SCOR, and HDS certifications, serving 25,000+ users.
- MonEcho Ultrasound consultation management solution generating structured reports with images and data for gynecologists, obstetricians, and midwives, serving 4,000+ professionals.
- DrSanté All-in-one medical practice management software simplifying administrative and medical management for healthcare professionals across 60+ specialties, with 8,000+ users. Holds Ségur, ASIP V2, LAP, and SCOR certifications.
- VIDAL Recos Therapeutic strategies and decision trees database with over 185 validated therapeutic strategies and 260+ decision trees providing clinical practice guidelines for healthcare professionals.
Quantifiable outcome
- Reduction in serious adverse drug events through prescription monitoring
- +2 more outcomes
Companies that use VIDAL
Customer profileNamed customers5 records
Segments5 records
Ideal customer profiles5 records
VIDAL technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration48 records
AI capability4 records
Feature5 records
VIDAL partnerships and signals
Strategic signalPartnerships
Ten partnerships are on record, tiered core and minor.
- Calimaps (DrSanté)coreCalimaps, developer of DrSanté software, joined VIDAL Group in 2023. DrSanté is an all-in-one medical management solution with 8,000+ users across 60+ specialties, featuring Segur, ASIP V2, LAP, and SCOR certifications.
- Mon Espace SantécoreVIDAL was selected in February 2021 to participate in the construction of Mon Espace Santé (My Health Space), France's national health data platform, contributing its patient health information expertise.
- MonEchocoreMonEcho, the French market leader in obstetrics-gynecology ultrasound management software with 15 years of expertise, joined VIDAL Group in November 2020. The solution generates structured ultrasound reports integrating images and data, serving 4,000+ professionals.
- WEDAcoreWEDA, a leading online medical software company founded in 2011, became a VIDAL Group subsidiary in September 2019. The integration allows VIDAL to directly embed its medical knowledge into WEDA's patient record and prescription management platform serving 25,000+ users.
- Software Publisher Partners (280+)coreVIDAL partners with over 280 software publishers who integrate VIDAL's medical knowledge base into their healthcare software products. This includes 87 city medicine software, 107 hospital software, 15 pharmacy software, 11 dental software, and 8 health center software solutions. Major partners include Dedalus Healthcare, CEGI, Berger Levrault, CompuGroup Medical, GE Healthcare, Softway Medical, InterSystems, and many others covering the full spectrum of French healthcare software.
- Health Data HubcoreVIDAL was selected as a laureate of the first Health Data Hub call for projects in 2019 with the PIMPON project (Priorisation des Interactions Médicamenteuses par leur PONdération clinique), focused on prioritizing drug interactions through clinical weighting.
- HAS (Haute Autorité de Santé)coreVIDAL's therapeutic recommendations and database are based on HAS guidelines and validation. The company obtained HAS V2 approval for its healthcare database in November 2014 and continues to integrate HAS recommendations into its products.
- ANSM (Agence nationale de sécurité du médicament)coreVIDAL integrates regulatory information and safety alerts from ANSM (French National Agency for Medicines and Health Products Safety) into its medical database for validated medication information.
- EMA (European Medicines Agency)coreVIDAL incorporates European regulatory data from EMA into its database, providing international perspective alongside French-specific information.
- GIE-SIPS and CNHIMminorIn March 2017, VIDAL launched MedicaBase with GIE-SIPS and CNHIM, creating an interoperability reference for approved database interoperability standards.
Scale indicators6 records
Recent moves6 records
Expansion highlights6 records
VIDAL competitors and assessment
Company assessmentDirect peers
- First Databank (FDB): FDB is the leading US medication decision support database, embedded in most major EHR systems for drug-interaction, dosing, and screening checks. It is the closest direct functional peer to VIDAL's core medication knowledge base, though focused primarily on the US market.
Broad incumbents
- Wolters Kluwer: Wolters Kluwer operates Medi-Span (drug data) and Lexicomp (clinical drug reference), and UpToDate (clinical decision support), making it a broad incumbent with overlapping medication-safety, dosing, and CDS capabilities that compete with VIDAL at the hospital level across global markets.
- Elsevier (RELX): Elsevier publishes ClinicalPath, ClinicalKey, and the legacy Gold Standard Drug Database, providing drug information and clinical decision support to hospitals and clinicians globally. It competes with VIDAL in higher-tier hospital CDS and drug-reference content.
- CompuGroup Medical: CompuGroup Medical is a major European health-IT vendor whose practice management and hospital systems (e.g., MEDISTAR, Axisanté, Clickdoc) embed drug databases. It is simultaneously a VIDAL integration partner and a competitor for embedded medication data in DACH and Western European markets.
- Dedalus Group: Dedalus is one of VIDAL's largest hospital-software integration partners (DxCare, DxPharm) and a leading European HIS vendor. It is both a critical distribution channel for VIDAL's knowledge base and a potential long-term competitor should Dedalus vertically integrate drug-data capabilities.
Regional players
- MIMS: MIMS is a widely used drug reference in Asia-Pacific and select EMEA markets, providing validated drug monographs and decision support to clinicians. It competes with VIDAL in any international market where VIDAL seeks to expand via eVIDAL.
- Rote Liste: Rote Liste is the standard German drug reference, comparable to the historical 'Dictionnaire VIDAL' in France. It is a regional peer that VIDAL would likely encounter when expanding into German-speaking markets.
- British National Formulary (NICE/BMJ): BNF is the UK drug formulary of record, already integrated into VIDAL Hoptimal for hospital users. As a regional reference, it represents both a partner content layer and a competing authority VIDAL would face in the UK and Commonwealth markets.
Emerging players
- OpenEvidence: OpenEvidence is an AI-native clinical decision support tool backed by major medical publishers, providing drug and treatment answers for clinicians using LLMs. It represents the emerging AI-native competitive threat to curated drug databases such as VIDAL's.
Others
- Doctolib: Doctolib is the dominant French digital health platform for appointment booking, teleconsultation, and practice management. It is both a VIDAL integration partner (WEDA, Hellodoc integrations) and an adjacent ecosystem participant shaping French clinicians' software stack.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
VIDAL social profiles
Digital presenceVIDAL compliance and trust
Trust signalCompliance11 records
VIDAL financial estimates
Financial estimateRevenue estimate
Valuation estimate
VIDAL leadership team
Management profileNumber of profiles
Profiles10 records
VIDAL subsidiaries and ownership
Company hierarchySubsidiaries3 records
VIDAL funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
VIDAL M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about VIDAL
What does VIDAL do?
VIDAL provides a validated medical knowledge base and clinical decision support system for healthcare professionals. Its products include desktop, web, and mobile solutions (VIDAL Expert, VIDAL.fr, VIDAL Mobile) that deliver drug monographs, drug interaction checking, contraindication alerts, therapeutic recommendations (VIDAL Recos), and prescription security modules. The company also licenses its knowledge base to over 280 healthcare software publishers and operates hospital and consumer health applications.
Is VIDAL a public or private company?
VIDAL is a private company. It is classified as unknown and is currently operating.
When was VIDAL founded?
VIDAL was founded in 1911. It employs 251 to 500 people.
Where is VIDAL based?
VIDAL is headquartered in Issy-les-moulineaux, France, in the Europe region.
How does VIDAL make money?
Four revenue lines are on record. Professional Software Subscriptions are the primary driver. The others are B2B Licensing to Software Publishers, enterprise Solutions for Healthcare Facilities and eVIDAL International Services.
Who are VIDAL's main competitors?
First Databank (FDB) is listed as a direct peer. Broad incumbents are Wolters Kluwer, Elsevier (RELX), CompuGroup Medical and Dedalus Group. Regional players are MIMS, Rote Liste and British National Formulary (NICE/BMJ). OpenEvidence is listed as an emerging player. Doctolib is listed as an others.
Does VIDAL have an API?
No public API is recorded for VIDAL.
What industry is VIDAL in?
VIDAL's product category is Clinical Decision Support Software. Its primary akta.pro industry code is HLACAGAB, Medication Safety, Dosing & Drug Interaction CDS, with a secondary code of HLACAKAK, Medication Safety, Pharmacovigilance & Adverse Event Reporting IT. Its NAICS code is 5132 and its SIC code is 8090.